• closedAccess   Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review 

      Ruiz-García, A.; Pallarés-Carratalá, Vicente; Serrano-Cumplido, A.; Escobar-Cervantes, C.; Barquilla-García, A.; Divisón-Garrote, J.A.; Turégano-Yedro, M.; Prieto-Díaz, M.A.; Cinza-Sanjurjo, Sergio; Alonso-Moreno, F.J.; Beato-Fernández, P.; García-Matarín, L.; Rey Aldana, Daniel; Martín-Rioboó, E.; Moyá-Amengual, A.; Crespo Sabarís, Rafael; Piera-Carbonell, A.; Romero-Vigara, J.C.; Carrasco-Carrasco, E.; Velilla-Zancada, S.; Seoane-Vicente, M.C.; Górriz-Teruel, J.L.; Polo-García, J.; Barrios, V. Sociedad Española de Médicos de Atención Primaria (2022-02)
      The efficacy and safety of acetylsalicylic acid (ASA) prophylaxis for the primary prevention of atherosclerotic cardiovascular disease (ACVD) remain controversial in people with diabetes (DM) without ACVD, because the ...